尿毒症毒素与钙调神经磷酸酶抑制剂的潜在相互作用:肾移植受者研究
DRUGTOX横断面研究纳入403例肾移植后接受钙调神经磷酸酶抑制剂治疗监测的成人患者,检测五种尿毒症毒素与免疫抑制剂谷浓度的剂量校正比值。多因素分析显示,校正性别、年龄和BMI后,硫酸吲哚酚与他克莫司C0:D比值独立相关(OR 1.36,95%CI 1.00-1.85),而环孢素仅与年龄、性别、BMI及TMAO单变量相关。
要点
- 硫酸吲哚酚与他克莫司剂量校正谷浓度独立正相关。
- 环孢素剂量校正谷浓度未显示与PCS、IxS、IAA或尿素相关。
- 肾移植后尿毒症毒素蓄积可能影响他克莫司暴露。
核心结论
- 尽管治疗药物监测和剂量调整使免疫抑制剂水平保持在治疗窗内,他克莫司(而非环孢素)暴露增加与PCS、IxS和尿素蓄积相关。
研究设计与样本
- DRUGTOX为横断面研究,纳入2019年8月至2020年3月期间403例接受钙调神经磷酸酶抑制剂治疗药物监测的成人肾移植受者。
主要发现
- 中位年龄56岁(IQR 48-66),中位eGFR 41 mL/min/1.73 m2(IQR 30-57)。
- 年龄、性别、BMI、尿素、IxS和PCS均与他克莫司C0:D比值升高显著相关。
- 多因素分析校正性别、年龄和BMI后,IxS与他克莫司C0:D比值独立相关(OR 1.36,95%CI 1.00-1.85),校正年龄后PCS和尿素的关联减弱。
- 单变量logistic分析中,年龄、性别、BMI和TMAO水平(而非PCS、IxS、IAA或尿素)与环孢素C0:D比值升高显著相关。
临床怎么用
- 肾移植受者接受他克莫司治疗时,需关注尿毒症毒素蓄积对药物暴露的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The uraemic toxins that accumulate as renal function deteriorates can potentially affect drug pharmacokinetics. This study's objective was to determine whether plasma concentrations of certain uraemic toxins are correlated with blood concentrations of two immunosuppressants. METHODS: DRUGTOX was a cross-sectional study of 403 adult patients followed up after kidney transplantation and who had undergone therapeutic drug monitoring (TDM) of calcineurin inhibitors (tacrolimus or cyclosporin) between August 2019 and March 2020. For each patient, immunosuppressant trough concentrations (C0) were measured in whole blood samples and then normalized against the total daily dose (C0:D ratio). The sample was assayed for five uraemic toxins [urea, trimethylamine N-oxide (TMAO), indole acetic acid (IAA), p-cresylsulphate (PCS) and indoxylsulphate (IxS)] using liquid chromatography-tandem mass spectrometry. RESULTS: The median age was 56 years [interquartile range (IQR) 48-66] and the median estimated glomerular filtration rate was 41 mL/min/1.73 m2 (IQR 30-57). Age, sex, body mass index (BMI), urea, IxS and PCS were significantly associated with an increment in the tacrolimus C0:D ratio. A multivariate analysis revealed an independent association with IxS [odds ratio 1.36 (95% confidence interval 1.00-1.85)] after adjustment for sex, age and BMI, whereas adjustment for age weakened the association for PCS and urea. In a univariate logistic analysis, age, sex, BMI and the TMAO level (but not PCS, IxS, IAA or urea) were significantly associated with an increment in the cyclosporine C0:D ratio. CONCLUSIONS: Even though TDM and dose adaptation of immunosuppressants keep levels within the therapeutic window, increased exposure to tacrolimus (but not cyclosporine) is associated with an accumulation of PCS, IxS and urea.
引用
- André C, Choukroun G, Bennis Y, et al. Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors. Nephrol Dial Transplant. 2022. PMID: 33783543. doi:10.1093/ndt/gfab114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。